Target intelligence / Profile preview

Transcription factor HES5 (HES5)

Target
HES5
Molecular classification
Transcription factor, Basic helix-loop-helix (bHLH) protein
01

Overview

Transcription factor HES5 (Hairy and enhancer of split 5) is a basic helix-loop-helix (bHLH) protein that serves as a primary downstream effector of the Notch signaling pathway [UniProt: Q5TA89]. It functions as a transcriptional repressor, typically binding to N-box sequences in the promoters of proneural genes to inhibit their expression and maintain stem cells in an undifferentiated state [NCBI Gene: 388585]. In the central nervous system, HES5 plays a critical role in regulating the balance between neural stem cell self-renewal and differentiation into neurons or glia [PubMed: 17629545]. Dysregulation of HES5 is frequently observed in various malignancies, including glioblastoma and medulloblastoma, where its overexpression promotes tumor cell stemness and resistance to therapy [PubMed: 31213565]. While small molecule inhibitors directly targeting HES5 are challenging to develop due to its nature as a transcription factor, HES5 mRNA represents a viable therapeutic target for RNA-based modalities like siRNA or antisense oligonucleotides [PubMed: 28671665]. By reducing HES5 levels, these therapies aim to induce differentiation in cancer stem cells or restore normal developmental programs [PubMed: 25661153].

Other names
Hairy and enhancer of split 5bHLHb38Class B basic helix-loop-helix protein 38HES-5
02

Mechanism of action

RNA interference (siRNA) or antisense oligonucleotides (ASO) targeting HES5 mRNA to prevent translation of the HES5 repressor protein, thereby promoting cellular differentiation.

03

Biological functions

Notch signaling pathwayNeurogenesisCell fate determinationTranscriptional repressionStem cell maintenance
04

Disease associations

CancerGlioblastomaMedulloblastomaNeurodevelopmental disorders
05

Safety considerations

Potential for neurotoxicityDisruption of normal stem cell nichesOff-target effects on other bHLH family membersDevelopmental toxicity
06

Interacting drugs

Experimental siRNA

1 more in the full profile.

07

Biomarkers

HES5 mRNA expression levelsNotch pathway activation statusASCL1 expression levels

Beyond the preview

Go deeper on Transcription factor HES5 (HES5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transcription factor HES5 (HES5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call